Patents by Inventor Trevor Lockett

Trevor Lockett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE
    Publication number: 20210244692
    Abstract: The present invention relates to methods for treating or preventing or delaying the progression or onset of autoimmune disease, comprising the use of dietary metabolites.
    Type: Application
    Filed: February 17, 2021
    Publication date: August 12, 2021
    Applicants: MONASH UNIVERSITY, COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
    Inventors: CHARLES REAY MACKAY, Eliana Marino Moreno, Trevor Lockett, Julie Clarke, David Topping
  • METABOLITES FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE
    Publication number: 20190167615
    Abstract: The present invention relates to methods for treating or preventing or delaying the progression or onset of autoimmune disease, providing dietary metabolites comprising a combination of two or more short chain fatty acids, esters or salts thereof. The present invention also provides compositions for treating, preventing or delaying the progression of, or onset of autoimmune disease.
    Type: Application
    Filed: August 10, 2017
    Publication date: June 6, 2019
    Applicants: MONASH UNIVERSITY, COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR
    Inventors: Charles REAY MACKAY, Eliana Marino MORENO, Trevor LOCKETT, Julie CLARKE, David TOPPING
  • Composition and method for killing of tumours
    Publication number: 20060177423
    Abstract: The present invention provides a method of treating a solid tumour in a subject, the method comprising the following steps (i) delivering to the solid tumour a composition comprising an engineered ovine atadenovirus; and (ii) administering a prodrug to the subject, wherein the engineered ovine atadenovirus comprises a promoter and a gene encoding an enzyme which converts the prodrug to a cytotoxic metabolite, the gene being under control of the promoter.
    Type: Application
    Filed: March 28, 2003
    Publication date: August 10, 2006
    Inventors: Gerald Both, Trevor Lockett, Peter Molloy, Fiona Cameron, Pamela Russell, Rosetta Martiniello-Wilks, Minoo Moghaddam, Ian Smith
  • Delivery of dsrna to arthropods
    Publication number: 20050095199
    Abstract: The invention is to methods of gene silencing in arthropods using dsRNA. The method is include contacting the arthropod with, and/or directly feeding the arthropod, the dsRNA to the arthropods to deliver the dsRNA to arthropod tissues. It is envisaged that the methods of the invention will have use in determining the biological function of genes in arthropods. Methods of pest control of arthropods, and of protecting arthropods against parasites and predators are provided. Transgenic arthropods expressing dsRNA molecules are also provided by the present invention.
    Type: Application
    Filed: July 5, 2002
    Publication date: May 5, 2005
    Inventors: Steven Whyard, Fiona Cameron, Minoo Moghaddam, Trevor Lockett
  • Optimized minizymes and miniribozymes and uses thereof
    Patent number: 6277634
    Abstract: This invention is directed to improved catalytic compounds, minizymes and miniribozymes, capable of hybridizing with a target RNA to be cleaved. The minizymes and miniribozymes and compositions of the present invention may be used in vitro or in vivo. They may be used as diagnostic or therapeutic agents.
    Type: Grant
    Filed: May 18, 1998
    Date of Patent: August 21, 2001
    Assignee: Commonwealth Scientific and Industrial Research Organization
    Inventors: Maxine J. McCall, Philip Hendry, Trevor Lockett
  • Optimized minizymes and miniribozymes and uses thereof
    Patent number: 6004806
    Abstract: This invention is directed to improved catalytic compounds, minizymes and miniribozymes, capable of hybridizing with a target RNA to be cleaved. The minizymes and miniribozymes and compositions of the present invention may be used in vitro or in vivo. They may be used as diagnostic or therapeutic agents.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 21, 1999
    Assignee: Commonwealth Scientific and Industrial Research Organization
    Inventors: Maxine J. McCall, Philip Hendry, Trevor Lockett
  • Optimized minizymes and miniribozymes and uses thereof
    Patent number: 6001648
    Abstract: This invention is directed to improved catalytic compounds, minizymes and miniribozymes, capable of hybridizing with a target RNA to be cleaved. The minizymes and miniribozymes and compositions of the present invention may be used in vitro or in vivo. They may be used as diagnostic or therapeutic agents.
    Type: Grant
    Filed: December 18, 1995
    Date of Patent: December 14, 1999
    Assignee: Commonwealth Scientific and Industrial Research Organization
    Inventors: Maxine J. McCall, Philip Hendry, Trevor Lockett